Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) is trading up 13% after Roche Holding AG delayed development of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE